PL345500A1 - Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies - Google Patents

Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Info

Publication number
PL345500A1
PL345500A1 PL99345500A PL34550099A PL345500A1 PL 345500 A1 PL345500 A1 PL 345500A1 PL 99345500 A PL99345500 A PL 99345500A PL 34550099 A PL34550099 A PL 34550099A PL 345500 A1 PL345500 A1 PL 345500A1
Authority
PL
Poland
Prior art keywords
vitamin
vulvitis
esters
topical treatment
dryness
Prior art date
Application number
PL99345500A
Other languages
English (en)
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Giorgio Panin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL345500(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giorgio Panin filed Critical Giorgio Panin
Publication of PL345500A1 publication Critical patent/PL345500A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL99345500A 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies PL345500A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose

Publications (1)

Publication Number Publication Date
PL345500A1 true PL345500A1 (en) 2001-12-17

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345500A PL345500A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Country Status (22)

Country Link
EP (1) EP1094807B1 (https=)
JP (1) JP2002520281A (https=)
CN (1) CN1135975C (https=)
AT (1) ATE238051T1 (https=)
AU (1) AU762860B2 (https=)
BR (1) BR9911945A (https=)
CA (1) CA2336990A1 (https=)
CZ (1) CZ301019B6 (https=)
DE (1) DE69907193T2 (https=)
DK (1) DK1094807T3 (https=)
ES (1) ES2196813T3 (https=)
HU (1) HU228921B1 (https=)
IL (1) IL140759A0 (https=)
IT (1) ITMI981586A1 (https=)
NO (1) NO20006719L (https=)
NZ (1) NZ509129A (https=)
PL (1) PL345500A1 (https=)
PT (1) PT1094807E (https=)
RU (2) RU2221561C2 (https=)
SK (1) SK284464B6 (https=)
TR (2) TR200100014T2 (https=)
WO (1) WO2000002554A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
JP2008531603A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 脂質低下特性を有する化合物
CN107468648A (zh) * 2008-10-09 2017-12-15 拉姆斯科股份有限公司 治疗干眼综合征的组合物和方法
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
US9192594B2 (en) * 2009-07-27 2015-11-24 Renato Sanseverino Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
EP2760433B1 (en) 2011-09-29 2023-05-31 PLx Opco Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
CN104507465A (zh) * 2012-06-08 2015-04-08 俄亥俄州立大学 使用生育三烯酚治疗灼伤和瘢痕损伤
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
CA2965184A1 (en) 2014-10-22 2016-04-28 Bio.Lo.Ga. S.R.L. Pharmaceutical composition comprising ester of alpha tocopherol and oily vehicle for use in increasing the trophism of nasal mucosa
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) * 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド pH依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンe点眼剤
JP3551977B2 (ja) * 1993-04-08 2004-08-11 ライオン株式会社 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
CN1135975C (zh) 2004-01-28
ES2196813T3 (es) 2003-12-16
HUP0102781A2 (hu) 2001-12-28
CZ200136A3 (cs) 2001-08-15
NO20006719L (no) 2001-02-16
ATE238051T1 (de) 2003-05-15
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
NZ509129A (en) 2003-10-31
HUP0102781A3 (en) 2002-04-29
RU2003128023A (ru) 2005-04-10
HU228921B1 (en) 2013-06-28
AU762860B2 (en) 2003-07-10
IL140759A0 (en) 2002-02-10
DE69907193T2 (de) 2004-04-08
NO20006719D0 (no) 2000-12-29
CA2336990A1 (en) 2000-01-20
EP1094807A1 (en) 2001-05-02
ITMI981586A1 (it) 2000-01-10
TR200100014T2 (tr) 2001-06-21
ITMI981586A0 (it) 1998-07-10
JP2002520281A (ja) 2002-07-09
DE69907193D1 (de) 2003-05-28
TR200103710T2 (tr) 2002-06-21
SK352001A3 (en) 2001-06-11
EP1094807B1 (en) 2003-04-23
CN1308531A (zh) 2001-08-15
AU4385899A (en) 2000-02-01
PT1094807E (pt) 2003-08-29
BR9911945A (pt) 2001-03-27
CZ301019B6 (cs) 2009-10-14
DK1094807T3 (da) 2003-08-11
RU2221561C2 (ru) 2004-01-20

Similar Documents

Publication Publication Date Title
PL345500A1 (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
NO20044699L (no) Vaginalpleiesammensetning
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
MXPA05002033A (es) Una composicion farmaceutica.
PT1147110E (pt) Derivados de pirazino (aza)-indol
WO2003070178A3 (en) Throat spray
AU2002251009A1 (en) Tiotropium salts for treating inflammatory diseases
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
SE9900070D0 (sv) New use
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
ATE360428T1 (de) Analgetisches arzneimittel
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
DK1105141T3 (da) Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
FR2802097B1 (fr) Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
IT1150752B (it) Dispositivo sanitario per una crio-farmaco terapia topica sintomatica di malattie benigne ano-rettali, in particolari di emorroidi
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
SE0103325D0 (sv) Novel compounds
WO1999058107A3 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
JPS6447717A (en) Infectious disease preventing drug
ITMI991144A1 (it) Acido tricloroacetico per la preparazione di soluzioni e/o composizioni per il trattamento di lesioni erosive e/o ulcerative
RU2000106782A (ru) Применение препарата "юницивин" для лечения воспалительных процессов в матке женщин
CN1421216A (zh) 疮疡散
RU2003117503A (ru) Способ лечения и профилактики рецидивов генитальной папилломавирусной инфекции

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)